POSTER SESSION
Poster Instructions: Guidelines

Your poster can be presented
during Lunches & Poster Viewing Session
The text must be typed in single line spacing in black using 12 pitch character.

It must be 70 centimetres wide (across) and 100 centimetres high (vertical).

You may display your poster from 21st June 2006 at 14h00. Your presence near it is kindly requested during lunches and coffee breaks for discussion.

Please PRINT THE POSTER including the names of the authors and the title.
LEGEND
A =  PREDICTION OF PROGNOSIS AND RESPONSE: THE USE OF GENETIC PROFILING
B = PRECANCEROUS DISORDERS: FROM GENE TO PHENOTYPE
C =  CHEMOPREVENTION
D =  IMAGING OF BREAST CANCER: CURRENT AND FUTURE METHODS
E = PROGRESS IN SURGICAL METHODS
F =  RADIATION THERAPY: WHEN, HOW, FOR WHOM
G =  ENDOCRINE ADJUVANT THERAPIES: ONGOING RESEARCH. DO WE HAVE NEW STANDARDS?
H = PREOPERATIVE SYSTEMIC THERAPIES: TAILORED APPROACH
I = ADJUVANT TREATMENT FOR SPECIAL POPULATIONS
L = APPROACHING COMPLICATIONS OF METASTATIC BREAST CANCER AND PARANEOPLASTIC SYNDROMES. WHAT'S NEW?
M = THE OLDER WOMAN WITH BREAST CANCER
N = MISCELLANEOUS
POSTER LIST
Cat  Title
A1  Cyclooxygenase-2 expression on tissue microarrey of breast cancer
Han Sehwan
A2  Analysis of cytokeratin positive cells from bone marrow reveals eraly metastasis in breast cancer
Jung Yongsik
A3  Preliminary evidence of electron transport chain dysfunctions in breast cancer cell mitochondria
Signore Fabrizio
A4  Chemotherapy influeneces inducible nitric oxide synthase (INOS) and endothelial nitric oxide synthase (ENOS) activity on 30 breast cancer cell line
Oktem Gulperi
A5  April 2006 update of immunohistochemical comparison between gastrointestinal stromal tumors (GIST) and solitary fibrous tumors (SFT): ASL 20-22 experience
Maccarini Elena
A6  In vitro induction of carcinoembryonic antigen (CEA) specific cytotoxic T lymphocytes using dendric cells pulsed with a CEA peptide
Yoon JH
A7  Influence on endocrine therapy of receptor tyrosine kinase receptors (RTK's) and downstream signaling mitogen activated protein kinases (p38 MAPK) - A comparative study of immunohistochemistry on tissue micro array (TMA) and Elisa in tumour homogenates
Linderholm Barbro
A8  Comprehensive genetic and epigenetic aberrations in breast cancer
Shadeo Ashleen
   
B1  Histological evaluation of the resection margin for percutaneous excision of breast fibroadenoma with using ultrasound-guided mammotome
Kim Hyun-Ah
B2  Cytologic grading of breast carcinoma, correlation with histologic grading and regional lymph node metastasis
Kadivar Maryam
B3  Polymorphism [Ile(655)Val] of HER-2 gene and risk of breast fobroadenoma
Dussan Carlos Alberto
   
D1  The use of gel markers for localisation of impalpable breast lesions
Pugh Claire
D2  Preoperative assessment of breast lesions by 3-D imaging and 3-D power doppler
Dimitrakakis Costantine
D3  Sonographically guided vacuum-assisted breast biopsy: experience of an Italian center
Falcini Fabio
D4  Washout rates of 99mTc-MIBI in breast cancer: correlation with neoadjuvant chemotherapy
Kwak Hi Suk
D5  Non-invasive three dimensional optical mammography
Richardson Caroline E
D6  Radioguided occult lesion localization (ROLL) of the non palpable primary breast lesions
Taffurelli Mario
   
E1  Sentinel lymph node biopsy versus axillary clearance in operable breast cancer (SNAC trial). A multicentre randomised trial of the royal Australasian College of Surgeons section of breast surgery in collaboration with the National Health & Medical Reserach Council Clinical Trial Centre
Gill Grantley P
E2  Breast Surgery today: oncoplastic surgery flows extensive resections and cosmetics for breast conservative treatment of breast carcinomas
Danaei Mahmoud
E3  Breast conserving surgery with volume replacement using latissimus dorsi musculocutaneous flap
Aono Toyokazu
E4  Breast, nipple and areola reconstruction in rural India
Pote Vijay
E5  Central quadrantectomy: is it a viable alternative to mastectomy in the treatment of central breast cancers?
Kim SK
E6  The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer
Madsen Eva 
E7  Omega and inverted omega incision - A concept of uniform incision in breast surgery
Vlajcic Zlatko
E8  Nipple areola complex preservation: predictive factors of nepolastic NAC incasion
Vlajcic Zlatko
E9  Local recurrence afetr nipple-areola-skin sparing mastectomy for patients with breast carcinoma
Kang Su Hwan
E10  Incidence of axillary recurrence in 105 sentinel node negatiove breast cancer patients
Casella Donato
E11  Sentinel lymph node biopsy in breasy cancer: experience at Hospital of Carrara
Lombardi Mirko
E12  Radioguided occult lesion localization (ROLL) of the non palpable suspicious breast lesions: initial experience
Fatih Aydogan
E13  The significance of cyclooxygenase-2 in sentinel lymph node in breast cancer. A possible resolution of false negative result
Liu Tse-Jia
   
F1  Intraoperative radiotherapy (IORT) adopting intrabeam device in breast cancer: experiences on 27 cases
Fiorentini Giammaria
F2  Close or positive margins following mastectomy for ductal carcinoma in situ (DCIS): patterns of relaps and potential indications for radiotherapy
Shahrokh Iganej
   
G1  A case of gingival hypertrophy caused by tamoxifen
Baratelli Giorgio M
G2  Hormone replacement therapy (HRT) is effective for tamoxifen-induced oestrogen deficiency symptoms: the UK HRT trial
Marsden Jo
   
H1  DOCK4 is frequently extinguished in sporadic breast cancer
Aghajani Ali
H2  Primary chemotherapy with TAC regimen in large operable breast cancer: outcome and toxicity
Giardina Giovanni
H3  Role of intercellular communications in breast cancer multicellular tumor spheroids after chemotherapy
Goksel Gamze
H4  Comparison of tissue gamma-butyrolactone(GBL) concentration and clinical response of UFT in operable breast cancer patient
Aono Toyokazu
H5  Apoptotic effect of UFT administered preoperatively in breast cancer patients
Aono Toyokazu
   
I1  Clinical study of breast cancer patients with more than 10 positive axillary lymph nodes
Jin-Sun Lee
   
L1  Split, low-dose Docetaxel (D) and low-dose Capecitabine (C) is an active regimen in metastatic breast cancer with minimal toxicity: preliminary results of a Phase II trial
Lopes Gilberto
L2  Solitary nodules in patients with breast cancer
Bhimji Shabir
L3  Malignant pleural effusions in metastatic breast cancer
Bhimji Shabir
L4  Nanoparticle albumin-bound (Nab) paclitaxel (P) in combination with bevacizumab (B) with and without gemcitabine (G): Early experience at the University of Miami/Braman Breast Cancer Institute
Lobo Christopher
L5  Capecitabine monotherapy in taxane-refractory metastatic breast cancer (MBC) patients
Je-Ryong Kim
L6  Clodronate and breast cancer survival
Ha Tam
   
M1  Radiofrequency ablation for minimally invasive treatment of breast carcinoma. A pilot study in elderly inoperable patients
Susini Tommaso
M2  Elderly patients with early breast cancer: a retrospective study
Santoriello Antonio
M3  Vinorelbine and gemcitabine for metastatic breast cancer in patients older than 70 years
Basso Umberto
   
N1  Psychological support for women with breast cancer in relation to psycho-neuroendocrine-immune system (PNI)
Corsi G
N2  Breast cancer in women under 35 years of age
Papadiamantis Ioannis
N3  The prognostic impact of HER-2 overexpression/amplification on invasive ductal carcinoma of the breast according to hormone receptor status
Kang Sung-Soo
N4  Prevention of oxaliplatin-induced neurotoxicity with calcium-magnesium infusion: our experience
Simoni Carlotta
N5  Complementary and alternative medicine use in breast cancer patients in Korea
Song Byung-Joo
N6  Psycho-nutritional theprapy: an integrative approach to supportive care
Serin Daniel
N7  Breast cancer - Retrospective study in past five years
Matic Ivan
N8  Malignant melanoma metastatic to the male breast: a case report
Fatih Aydogan
N9  Recurrence risk assessment in ductal carcinoma in situ of the breast
Di Seri Marisa
N10  Six male breast carcinoma case presentations: interdisciplinary group ASL 20-22 experience
Pacquola Maria Grazia
N11  Two cases of primary non-hodgkin lymphoma of the breast: clinical description
Simoni Carlotta
N12  Incidence of BRCA1-2 mutations in ASL 20-22 population: 1 year experience
Pacquola Maria Grazia
N13  Breast cancer
Sadok M